Concepts (113)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Molecular Diagnostic Techniques | 1 | 2009 | 152 | 0.280 |
Why?
|
| Vaginal Smears | 1 | 2007 | 48 | 0.260 |
Why?
|
| Communicable Diseases | 1 | 2009 | 160 | 0.260 |
Why?
|
| Papillomaviridae | 1 | 2007 | 145 | 0.250 |
Why?
|
| Placenta | 2 | 2019 | 508 | 0.230 |
Why?
|
| Gammaproteobacteria | 1 | 2024 | 15 | 0.220 |
Why?
|
| Hand Injuries | 1 | 2023 | 16 | 0.200 |
Why?
|
| Papillomavirus Infections | 1 | 2007 | 296 | 0.200 |
Why?
|
| Fungi | 1 | 2023 | 69 | 0.200 |
Why?
|
| Lacerations | 1 | 2023 | 33 | 0.200 |
Why?
|
| Lasers | 1 | 2023 | 114 | 0.200 |
Why?
|
| Bacteriuria | 1 | 2022 | 47 | 0.190 |
Why?
|
| Mycoplasma genitalium | 1 | 2021 | 2 | 0.190 |
Why?
|
| Mycoplasma Infections | 1 | 2021 | 8 | 0.190 |
Why?
|
| Phage Therapy | 1 | 2021 | 29 | 0.180 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 139 | 0.160 |
Why?
|
| Prosthesis-Related Infections | 1 | 2021 | 173 | 0.160 |
Why?
|
| Urinary Tract Infections | 1 | 2022 | 237 | 0.150 |
Why?
|
| Gram-Positive Bacteria | 1 | 2019 | 47 | 0.150 |
Why?
|
| Blood Culture | 1 | 2019 | 30 | 0.150 |
Why?
|
| Enema | 1 | 2018 | 37 | 0.150 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2018 | 97 | 0.140 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2019 | 362 | 0.140 |
Why?
|
| Zika Virus | 1 | 2019 | 144 | 0.140 |
Why?
|
| Zika Virus Infection | 1 | 2019 | 171 | 0.130 |
Why?
|
| Health Care Costs | 1 | 2019 | 371 | 0.120 |
Why?
|
| Diabetes Mellitus | 1 | 2024 | 873 | 0.120 |
Why?
|
| Clostridium Infections | 1 | 2018 | 244 | 0.120 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 361 | 0.120 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 377 | 0.120 |
Why?
|
| Antibodies, Viral | 1 | 2020 | 1150 | 0.110 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2019 | 455 | 0.110 |
Why?
|
| Heart-Assist Devices | 1 | 2021 | 1026 | 0.100 |
Why?
|
| Pregnancy | 5 | 2024 | 7221 | 0.090 |
Why?
|
| Nucleic Acid Probes | 1 | 2009 | 1 | 0.080 |
Why?
|
| Sensitivity and Specificity | 2 | 2020 | 2055 | 0.080 |
Why?
|
| Government Regulation | 1 | 2009 | 41 | 0.080 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2009 | 65 | 0.080 |
Why?
|
| Quality Control | 1 | 2009 | 121 | 0.080 |
Why?
|
| Bacterial Typing Techniques | 1 | 2009 | 99 | 0.080 |
Why?
|
| Heart Failure | 1 | 2021 | 2297 | 0.070 |
Why?
|
| Genome, Bacterial | 1 | 2009 | 183 | 0.070 |
Why?
|
| Mass Spectrometry | 1 | 2009 | 335 | 0.070 |
Why?
|
| DNA, Bacterial | 1 | 2009 | 473 | 0.070 |
Why?
|
| Quality Assurance, Health Care | 1 | 2009 | 207 | 0.070 |
Why?
|
| False Negative Reactions | 1 | 2007 | 89 | 0.070 |
Why?
|
| Primary Health Care | 2 | 2024 | 766 | 0.070 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2007 | 53 | 0.070 |
Why?
|
| False Positive Reactions | 1 | 2007 | 144 | 0.070 |
Why?
|
| Humans | 12 | 2024 | 125110 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 1033 | 0.060 |
Why?
|
| Reference Values | 1 | 2007 | 719 | 0.060 |
Why?
|
| Prevalence | 2 | 2022 | 2458 | 0.060 |
Why?
|
| ROC Curve | 1 | 2007 | 571 | 0.060 |
Why?
|
| Cross-Sectional Studies | 2 | 2024 | 3402 | 0.060 |
Why?
|
| Drug Resistance, Multiple | 1 | 2024 | 47 | 0.060 |
Why?
|
| Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2024 | 38 | 0.050 |
Why?
|
| Ciprofloxacin | 1 | 2024 | 61 | 0.050 |
Why?
|
| Female | 7 | 2024 | 66704 | 0.050 |
Why?
|
| Fluoroquinolones | 1 | 2024 | 86 | 0.050 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2023 | 61 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 1 | 2009 | 1762 | 0.050 |
Why?
|
| Fatal Outcome | 1 | 2023 | 357 | 0.050 |
Why?
|
| Macrolides | 1 | 2021 | 29 | 0.050 |
Why?
|
| Predictive Value of Tests | 1 | 2007 | 2182 | 0.050 |
Why?
|
| Genomics | 1 | 2009 | 1520 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2024 | 791 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 2 | 2022 | 2371 | 0.040 |
Why?
|
| Serologic Tests | 1 | 2020 | 118 | 0.040 |
Why?
|
| Pregnant Women | 1 | 2021 | 143 | 0.040 |
Why?
|
| Immunoassay | 1 | 2020 | 131 | 0.040 |
Why?
|
| Algorithms | 1 | 2007 | 1630 | 0.040 |
Why?
|
| Pediatrics | 1 | 2009 | 1158 | 0.040 |
Why?
|
| DNA Barcoding, Taxonomic | 1 | 2019 | 15 | 0.040 |
Why?
|
| Term Birth | 1 | 2019 | 32 | 0.040 |
Why?
|
| Adult | 4 | 2022 | 29460 | 0.040 |
Why?
|
| RNA, Bacterial | 1 | 2019 | 54 | 0.040 |
Why?
|
| Freeze Drying | 1 | 2018 | 16 | 0.040 |
Why?
|
| Capsules | 1 | 2018 | 22 | 0.040 |
Why?
|
| Equipment Contamination | 1 | 2019 | 36 | 0.040 |
Why?
|
| Escherichia coli | 1 | 2024 | 968 | 0.040 |
Why?
|
| Symptom Assessment | 1 | 2019 | 101 | 0.040 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2021 | 358 | 0.040 |
Why?
|
| Cryopreservation | 1 | 2018 | 73 | 0.040 |
Why?
|
| In Situ Hybridization | 1 | 2019 | 472 | 0.040 |
Why?
|
| Metagenomics | 1 | 2019 | 102 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2023 | 1172 | 0.040 |
Why?
|
| Staphylococcus aureus | 1 | 2021 | 459 | 0.040 |
Why?
|
| Health Expenditures | 1 | 2019 | 103 | 0.040 |
Why?
|
| Betacoronavirus | 1 | 2020 | 290 | 0.030 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2019 | 243 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 372 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2018 | 683 | 0.030 |
Why?
|
| Syndrome | 1 | 2019 | 1119 | 0.030 |
Why?
|
| Microcephaly | 1 | 2019 | 331 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 1704 | 0.030 |
Why?
|
| Premature Birth | 1 | 2019 | 388 | 0.030 |
Why?
|
| Young Adult | 2 | 2019 | 9056 | 0.030 |
Why?
|
| Microbiota | 1 | 2019 | 387 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2021 | 16338 | 0.030 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2019 | 972 | 0.030 |
Why?
|
| Pandemics | 1 | 2020 | 1112 | 0.030 |
Why?
|
| Middle Aged | 2 | 2024 | 26676 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2021 | 6123 | 0.020 |
Why?
|
| Obesity | 1 | 2022 | 2244 | 0.020 |
Why?
|
| Risk Factors | 1 | 2024 | 10278 | 0.020 |
Why?
|
| Phenotype | 1 | 2019 | 4270 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2022 | 8275 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 6537 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 3600 | 0.020 |
Why?
|
| Brain | 1 | 2019 | 3014 | 0.020 |
Why?
|
| Male | 2 | 2024 | 61443 | 0.020 |
Why?
|
| Aged | 1 | 2018 | 19656 | 0.010 |
Why?
|